These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 20053773)
1. Global methylation pattern of genes in androgen-sensitive and androgen-independent prostate cancer cells. Mishra DK; Chen Z; Wu Y; Sarkissyan M; Koeffler HP; Vadgama JV Mol Cancer Ther; 2010 Jan; 9(1):33-45. PubMed ID: 20053773 [TBL] [Abstract][Full Text] [Related]
2. Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2'-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis. Tian J; Lee SO; Liang L; Luo J; Huang CK; Li L; Niu Y; Chang C J Biol Chem; 2012 Nov; 287(47):39954-66. PubMed ID: 23012352 [TBL] [Abstract][Full Text] [Related]
3. Progression to metastatic stage in a cellular model of prostate cancer is associated with methylation of the androgen receptor gene and transcriptional suppression of the insulin-like growth factor-I receptor gene. Schayek H; Bentov I; Sun S; Plymate SR; Werner H Exp Cell Res; 2010 May; 316(9):1479-88. PubMed ID: 20338164 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of MDR1 gene through post-translational histone modifications in prostate cancer. Henrique R; Oliveira AI; Costa VL; Baptista T; Martins AT; Morais A; Oliveira J; Jerónimo C BMC Genomics; 2013 Dec; 14():898. PubMed ID: 24344919 [TBL] [Abstract][Full Text] [Related]
5. Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer. Sasaki M; Tanaka Y; Perinchery G; Dharia A; Kotcherguina I; Fujimoto Si; Dahiya R J Natl Cancer Inst; 2002 Mar; 94(5):384-90. PubMed ID: 11880477 [TBL] [Abstract][Full Text] [Related]
6. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2. Pulukuri SM; Rao JS Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000 [TBL] [Abstract][Full Text] [Related]
7. Global methylation analysis identifies PITX2 as an upstream regulator of the androgen receptor and IGF-I receptor genes in prostate cancer. Schayek H; Bentov I; Jacob-Hirsch J; Yeung C; Khanna C; Helman LJ; Plymate SR; Werner H Horm Metab Res; 2012 Jun; 44(7):511-9. PubMed ID: 22495974 [TBL] [Abstract][Full Text] [Related]
8. Sensitization of androgen refractory prostate cancer cells to anti-androgens through re-expression of epigenetically repressed androgen receptor - Synergistic action of quercetin and curcumin. Sharma V; Kumar L; Mohanty SK; Maikhuri JP; Rajender S; Gupta G Mol Cell Endocrinol; 2016 Aug; 431():12-23. PubMed ID: 27132804 [TBL] [Abstract][Full Text] [Related]
9. Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells. Dai JL; Maiorino CA; Gkonos PJ; Burnstein KL Steroids; 1996 Sep; 61(9):531-9. PubMed ID: 8883219 [TBL] [Abstract][Full Text] [Related]
10. Methylation of Integrin α4 and E-Cadherin Genes in Human Prostate Cancer. Mostafavi-Pour Z; Kianpour S; Dehghani M; Mokarram P; Torabinejad S; Monabati A Pathol Oncol Res; 2015 Sep; 21(4):921-7. PubMed ID: 25743258 [TBL] [Abstract][Full Text] [Related]
11. Methylation mediated silencing of TMS1/ASC gene in prostate cancer. Das PM; Ramachandran K; Vanwert J; Ferdinand L; Gopisetty G; Reis IM; Singal R Mol Cancer; 2006 Jul; 5():28. PubMed ID: 16848908 [TBL] [Abstract][Full Text] [Related]
12. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer. Enokida H; Shiina H; Igawa M; Ogishima T; Kawakami T; Bassett WW; Anast JW; Li LC; Urakami S; Terashima M; Verma M; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R Cancer Res; 2004 Sep; 64(17):5956-62. PubMed ID: 15342374 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic repression of regulator of G-protein signaling 2 promotes androgen-independent prostate cancer cell growth. Wolff DW; Xie Y; Deng C; Gatalica Z; Yang M; Wang B; Wang J; Lin MF; Abel PW; Tu Y Int J Cancer; 2012 Apr; 130(7):1521-31. PubMed ID: 21500190 [TBL] [Abstract][Full Text] [Related]
14. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer. Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168 [TBL] [Abstract][Full Text] [Related]
15. Increased expression of androgen receptor coregulator MAGE-11 in prostate cancer by DNA hypomethylation and cyclic AMP. Karpf AR; Bai S; James SR; Mohler JL; Wilson EM Mol Cancer Res; 2009 Apr; 7(4):523-35. PubMed ID: 19372581 [TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1. Zaia A; Fraizer GC; Piantanelli L; Saunders GF Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720 [TBL] [Abstract][Full Text] [Related]
17. Methylation-mediated repression of GADD45alpha in prostate cancer and its role as a potential therapeutic target. Ramachandran K; Gopisetty G; Gordian E; Navarro L; Hader C; Reis IM; Schulz WA; Singal R Cancer Res; 2009 Feb; 69(4):1527-35. PubMed ID: 19190346 [TBL] [Abstract][Full Text] [Related]
18. Altered methylation of multiple genes in carcinogenesis of the prostate. Yamanaka M; Watanabe M; Yamada Y; Takagi A; Murata T; Takahashi H; Suzuki H; Ito H; Tsukino H; Katoh T; Sugimura Y; Shiraishi T Int J Cancer; 2003 Sep; 106(3):382-7. PubMed ID: 12845678 [TBL] [Abstract][Full Text] [Related]
19. Differentially expressed genes in the prostate cancer cell line LNCaP after exposure to androgen and anti-androgen. Coutinho-Camillo CM; Salaorni S; Sarkis AS; Nagai MA Cancer Genet Cytogenet; 2006 Apr; 166(2):130-8. PubMed ID: 16631469 [TBL] [Abstract][Full Text] [Related]
20. Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia. Devaney JM; Wang S; Funda S; Long J; Taghipour DJ; Tbaishat R; Furbert-Harris P; Ittmann M; Kwabi-Addo B Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):292-300. PubMed ID: 23896626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]